Perspectives

Perspectives

Commentary and highlights from contributors and readers

Managing High Blood Pressure: The Cardiologist’s Perspective

Do you treat many patients for hypertension who also have hematologic malignancies? We definitely do, and obviously, some of that prevalence is due to age....

@BldCancerDoc, Or How I Learned to Stop Worrying and Love Twitter

I am a recent convert to Twitter. For a while, I was the average Twitter Joe – following a few important people and being followed mainly...

Caregivers, Transitions, and a Chronic Disease Model

Diagnoses of hematologic malignancies are less common than solid tumor diagnoses, but several advances over the last decade have led to improved survival for...

Letter From a Cleveland Jail to the ABIM: Redux

Dear American Board of Internal Medicine, Remember me? I’m the guy who sent those other letters to you over the past couple of years, in...

Managing the Diabetic Patient: The Endocrinologist’s Perspective

Where do the areas of hematology and endocrinology intersect in diabetes management? I have found that, in order to do the endocrinology work that I...

What Can We Do? The Scope of APP Practice Patterns

As I opened the door to the exam room one sunny morning in Cleveland, Ohio, a patient stood to greet me. “Congratulations, you’re finally a...

A New Year, A New Set of Resolutions

It's the dawn of a new year, and I’m sure this is one of many columns in many different publications you will read in...

Belonging to a Club That Would Have Me as a Member

Even though I had practiced my oral presentation a bunch of times, I still cringed when the session moderator announced the abstract number, title,...

Managing Atrial Fibrillation: The Cardiologist’s Perspective

Dr. Flaker is also a member of the American College of Cardiology’s (ACC’s) Anticoagulation Initiative Work Group – a multidisciplinary quality effort to address...

What Should You Call Us?

Nurse practitioners, clinical nurse specialists, nurse anesthetists, nurse midwives, and physician’s assistants (PAs) are like most hematologic cancers and blood disorders: heterogeneous in presentation....
Advertisement

Current Issue

October 2019, Volume 5, Issue 12

This issue highlights the unintended consequences of fighting the nation’s opioid epidemic, considers the optimal frontline regimen for myeloma, and more.